 |
Randall Burt, MD, principal investigator, directs overall operation of the Hereditary Gastrointestinal Cancer Registry (HGCR) and the High Risk Cancer Research Clinics and Studies (HRCR), including the chemoprevention clinical trial (FAPEST). Dr. Burt is a gastroenterologist who specializes in inherited gastrointestinal conditions, he is a member of the Cancer Control and Population Sciences Program. He is also co-leader of the Gastrointestinal Cancers Program. |
 |
Kathryn R. Byrne, MD, co-investigator for FAPEST chemoprevention clinical trial and is also a gastroenterologist. Her research interests include colon cancer prevention. |
 |
Jewel Samadder, MD, co-investigator for HGCR and the FAPEST chemoprevention clinical trial and is also a gastroenterologist. His clinical interests focus on gastrointestinal cancer syndromes and endoscopic oncology. Dr. Samadder's research focuses on the early detection and prevention of colorectal cancer. |
 |
Deborah Neklason, PhD, co-investigator for HGCR and the FAPEST chemoprevention clinical trial, provides the research team with scientific and administrative guidance. Deborah is a molecular geneticist and a member of the Gastrointestinal Cancers Program. Her research focuses on the genetic basis of inherited forms of colon cancer. |
 |
Thérèse Tuohy, PhD, scientific advisor and co-investigator for HGCR, works with study investigators to analyze and interpret genetic data that determines appropriate family members to recruit into the registry. Thérèse, a molecular geneticist and genetic counselor, works closely with the clinical research coordinator to make referrals and address outreach needs. |
 |
|
 |
Cristina Christenson, study coordinator for HGCR and the FAPEST chemoprevention clinical trial, assists in the recruitment, enrollment and collection of study materials for our Spanish speaking participants. |
 |
Therese Berry, CCRP, clinical research coordinator for the FAPEST chemoprevention clinical trial, manages recruitment, enrollment and clinical aspects of the trial. Therese also maintains regulatory documentation, reporting, and correspondence with the IRB. |
 |
Michelle Done, study coordinator for the FAPEST chemoprevention clinical trial, assists with the management of the clinical trial. She helps coordinate recruitment, enrollment, and clinical aspects of the trial. She coordinates study sample collection and data management. |
 |
Danielle Sample, MPH, Research Assistant/Analyst for the FAPEST chemoprevention clinical trial, provides the team with assistance in data management and analysis, recruitment and enrollment, and patient management. |
 |
Kyle Morgan, information coordinator for HGCR, supervises medical data procurement and abstraction. He also coordinates tissue acquisition and research testing for the High Risk Cancer Research Clinics and Studies. |
 |
|
 |
Elizabeth A. Sexton, MA, CRC, CPM, manager of the High Risk Cancer Research Clinics and Studies, provides administrative resources and financial management for the HGCR. The HRCR focuses on clinical and research efforts for populations with genetic changes that raise the risk of developing certain cancers. |
 |
Kathleen Shafer, project coordinator of the HRCR, provides administrative assistance to the HGCR. |
 |
Nykole Sargent, laboratory technician, maintains sample storage and uses the patient samples to explain polyps and cancer at a molecular level. Nykole specifically looks for genetic evidence of the diagnoses and designs assays for epigenetic factors. |
Mikaela Larson, CCRP, and Laurel Smith, CCRP, clinical research coordinators for HGCR, manage recruitment, enrollment and collection of study materials from participants. Mikaela & Laurel also prepare and maintain regulatory documentation and correspondence with the IRB.
